Practical eminence and experience-based recommendations for use of TNF-α inhibitors in sarcoidosis.

CONCLUSION: Based on earlier studies and consensus amongst world's leading sarcoidologists, practical recommendations for the use of TNF-α inhibitors in sarcoidosis were established. These recommendations, with emphasis on indications, dosage and discontinuation regimens, have been developed to support the clinician in the management of refractory sarcoidosis patients. PMID: 25078637 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25078637?dopt=Abstract

Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - November 25, 2014 Category: Respiratory Medicine Tags: Sarcoidosis Vasc Diffuse Lung Dis Source Type: research